Print Page | Sign In | Join Today
News & Press
Filter news by category:

Read about recent events, essential information and the latest community news.

Have news company or personal news you'd like us to share? 

Submit news

Displaying page 6 of 18
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  >   >>   >| 

Company News
Wednesday, August 16, 2017
Cavion Appoints Papapetropoulos, M.D., Ph.D. as EVP, R&D and CMO »
Cavion, Inc., a clinical stage biopharmaceutical company, names Dr. Spyridon "Spyros" Papapetropoulos as Executive Vice Pr...
Tuesday, August 15, 2017
Research Center Construction Begins in Newport News »
W. M. Jordan Development Co. will begin construction on its first building in the Tech Center Research Park in Newport New...
Monday, August 14, 2017
LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach »
LifeNet Health, a leading global regenerative medicine company, will invest $12.25 million to expand its global headquarte...
Friday, August 11, 2017
Kaléo Offers Free AUVI-Q Auto-injectors to All US Public Elementary Schools »
Kaléo, begins a new charitable product donation program, offering AUVI-Q® (epinephrine injection, USP) Auto-injectors free...
Thursday, August 10, 2017
Biovista and Hewlett Packard Enterprise to collaborate on next generation AI and Big Data Analytics »
Biovista will collaborate with Hewlett Packard Enterprise (HPE) to advance Biovista's Project Prodigy Big Data AI healthca...
Wednesday, August 9, 2017
Diffusion Pharmaceuticals Selects Contract Research Organization for Phase 3 Clinical Trial »
Diffusion Pharmaceuticals, Inc., a clinical stage biotechnology company developing novel small molecule therapeutics for c...
Wednesday, August 2, 2017
Aperiomics Launches New Website »
Aperiomics is one of the rising stars of the biotech industry. The company is growing quickly and has drawn attention not...
Thursday, July 27, 2017
FDA Grants Kaléo Priority Review for AUVI-Q 0.1 mg »
Kaléo, a privately-held pharmaceutical company, was granted Priority Review by the U.S. Food and Drug Administration (FDA)...
Thursday, July 27, 2017
Diffusion Achieves Milestone For Planned Phase 3 Clinical Trial »
Diffusion Pharmaceuticals Inc., a clinical stage biotechnology company developing novel small molecule therapeutics for ca...
Wednesday, July 26, 2017
TypeZero Partners with Senseonics and Roche on ‘Artificial Pancreas’ »
Senseonics and TypeZero Technologies first tied up on “artificial pancreas” R&D in May, and now, Roche is getting in o...
Monday, July 24, 2017
Venebio Launches Tool to Help Reduce Opioid Overdoses »
Venebio Group, a leader in personalized risk prediction algorithms, today announced that its risk-screening tool for opioi...
Thursday, July 20, 2017
TechLab Receives FDA Clearance To Market Tri-Combo Parasite Screen »
TECHLAB, Inc., a leading developer and manufacturer of rapid non-invasive diagnostic tests for gastrointestinal diseases,...
Tuesday, July 11, 2017
ImmunArray Enters Partnership with Kindstar Global »
ImmunArray, a privately held molecular device company dedicated to the development of novel, blood-based in vitro diagnost...
Monday, July 10, 2017
AMPEL BioSolutions Works to Improve Patient Clinical Trial Experience »
As reported in the Richmond Times-Dispatch, in 50 years, only one treatment was approved by the U.S. Food and Drug Adminis...
Monday, July 10, 2017
IALR's Gwaltney Retires Leaving Virginia Legacy »
An agreement to serve as the interim executive director for a few months quickly evolved into a permanent position Jerry G...
Thursday, July 6, 2017
Robert Ruffolo Joins Diffusion Pharmaceuticals Board »
Diffusion Pharmaceuticals Inc., a clinical stage biotechnology company focused on the development of novel small molecule...
Wednesday, July 5, 2017
ImmunArray Completes TBI Study »
ImmunArray, a privately held molecular device company dedicated to the development of novel, blood-based in vitro diagnost...
Wednesday, June 28, 2017
ivWatch Wins Top Honors at Med Device Awards »
ivWatch, a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy, was the B...
Friday, June 23, 2017
Nominate an RVA Company to Watch! »
RVA Companies to watch is an annual award and celebration that shines a light on area businesses that have the potential t...
Tuesday, June 20, 2017
BIO Partners with the Center for Advancing Innovation in the Freedom from Cancer Startup Challenge »
The Biotechnology Innovation Organization (BIO), the world's largest biotech trade association, is teaming up with the Cen...
Monday, June 19, 2017
Virginia Catalyst Awarded $2.825M in Grants to 6 Collaborative Projects »
The Virginia Biosciences Health Research Corporation, known as Virginia Catalyst, has awarded $2.825 million in grants to...
Friday, June 16, 2017
Intrexon Integrates Gene Delivery Technology with Completion of GenVec Acquisition »
Intrexon Corporation, specializing in the engineering and industrialization of biology to improve the quality of life and...
Friday, June 9, 2017   (0 Comments - view/add)
ivWatch raises $14.8M »
ivWatch, a medical device manufacturer focused on improving the safety and effectiveness of intravenous (IV) therapy, rais...
Thursday, June 8, 2017
CEL-SCI Announces New Data for Its Rheumatoid Arthritis Vaccine Candidate »
CEL-SCI Corporation has published data from rheumatoid arthritis (RA) studies in Vaccine, a leading peer-reviewed journal...
Friday, June 2, 2017
Canon Receives ISO Certification and Launches Medical Device Contract Manufacturing Services »
Canon Virginia, Inc., a wholly owned subsidiary of Canon U.S.A., Inc., is extending its full range of manufacturing servic...
Wednesday, May 31, 2017
ATCC and One Codex Partner to Address Microbiome Research »
ATCC, a leader in biological materials development, management and standards, and One Codex, a leading microbial genomics...
Tuesday, May 30, 2017
Stago Group Aquires HemoSonics »
Stago has completed its acquisition of point-of-care blood diagnostics platform developer HemoSonics. Virginia Bio me...
Wednesday, May 24, 2017
PPD Expanding Vaccines Lab in Richmond »
PPD is expanding its vaccine sciences lab in Richmond, Virginia, by another 17,000 square feet and added vaccine efficacy...
Monday, May 22, 2017
Granules Pharmaceuticals Inc. to Expand Manufacturing in Fairfax County »
Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly-owned subsidi...
Monday, May 22, 2017
Brothers Receive ELITE Recognition »
Evan and Eric Edwards of Kaleo have been recognized as ELITE Entrepreneurs of 2017 by PM360. ELITE Awards represent Except...
Thursday, May 18, 2017
Immunomic Licenses CMV-Targeting Platform for LAMP-Vax Cancer Vaccines »
Immunomic Therapeutics has an exclusive license to Annias Immunotherapeutics’ platform covering technology for targeting c...
Friday, May 12, 2017
Senseonics and TypeZero Working to Develop Artificial Pancreas »
Senseonics Holdings, a medical technology company focused on the development and commercialization of Eversense®, a long-t...
Thursday, May 11, 2017
Ann Romney to Give Keynote at 2017 BIO International Convention »
Ann Romney, the former First Lady of Massachusetts, a New York Times best-selling author and global ambassador for the Ann...
Thursday, May 11, 2017
Va Neuroscience Initiative Adds Sentara »
The Virginia Biosciences Health Research Corporation-“the Catalyst”, has established the Virginia Neuroscience Initiative...
Thursday, May 11, 2017
A New Tool to Predict Your Chance of Cancer »
True Health Diagnostics just launched genTrue, a screening tool developed for primary care physicians. This tool could pre...

Displaying page 6 of 18
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  >   >>   >| 

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected